Traws Pharma, Inc. (TRAW)
(Delayed Data from NSDQ)
$0.34 USD
0.00 (0.88%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $0.32 -0.02 (-6.71%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Cash flow Statements
Fiscal Year End for Traws Pharma, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -18.95 | -18.96 | -16.16 | -25.16 | -21.50 |
Depreciation/Amortization & Depletion | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
Net Change from Assets/Liabilities | -0.30 | 1.48 | -3.59 | 1.49 | -0.33 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 1.30 | 1.17 | 0.26 | 0.58 | 0.99 |
Net Cash From Operating Activities | -17.93 | -16.29 | -19.49 | -23.08 | -20.83 |
Property & Equipment | -0.01 | 0.00 | 0.00 | -0.02 | -0.06 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.01 | 0.00 | 0.00 | -0.02 | -0.06 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 55.56 | 19.36 | 26.61 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 |
Net Cash from Financing Activities | 0.00 | 0.00 | 55.56 | 19.36 | 26.65 |
Effect of Exchange Rate Changes | 0.01 | -0.02 | -0.03 | 0.03 | -0.01 |
Net Change In Cash & Equivalents | -17.94 | -16.31 | 36.05 | -3.70 | 5.76 |
Cash at Beginning of Period | 38.76 | 55.07 | 19.03 | 22.73 | 16.97 |
Cash at End of Period | 20.82 | 38.76 | 55.07 | 19.03 | 22.73 |
Diluted Net EPS | -0.90 | -0.91 | -0.96 | -2.10 | -22.34 |
Fiscal Year End for Traws Pharma, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -128.13 | -4.98 | -18.95 | -14.76 | -10.03 |
Depreciation/Amortization & Depletion | 0.01 | 0.00 | 0.02 | 0.01 | 0.01 |
Net Change from Assets/Liabilities | -4.34 | 0.22 | -0.30 | 0.28 | 0.38 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 118.18 | 0.33 | 1.30 | 0.97 | 0.61 |
Net Cash From Operating Activities | -14.28 | -4.42 | -17.93 | -13.50 | -9.03 |
Property & Equipment | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
Acquisition/ Disposition of Subsidiaries | -3.65 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -3.65 | 0.00 | -0.01 | -0.01 | 0.00 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 14.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 14.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Effect of Exchange Rate Changes | -0.01 | -0.01 | 0.01 | 0.00 | 0.01 |
Net Change In Cash & Equivalents | -3.94 | -4.43 | -17.94 | -13.51 | -9.03 |
Cash at Beginning of Period | 20.82 | 20.82 | 38.76 | 38.76 | 38.76 |
Cash at End of Period | 16.89 | 16.39 | 20.82 | 25.24 | 29.73 |
Diluted Net EPS | -4.87 | -0.24 | -0.19 | -0.23 | -0.20 |